Celeste Krewson, Assistant Editor

GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.

A recent study exposed disparities in contraceptive counseling and use among hypertensive individuals, suggesting a need for tailored contraceptive options, particularly within Black communities.

Discover how FemaSeed, an innovative artificial insemination device by Femasys Inc, offers safe and effective fertility solutions through precise sperm delivery into the fallopian tube.

A recent study revealed Medicaid patients encounter significant obstacles to postpartum sterilization, shedding light on crucial health care access issues.

Delve into the implications of a study investigating maternal mortality tracking methods in the United States, as OB Hospitalist Group's Chief Medical Officer, Mark Simon, MD, highlights critical factors often overlooked and emphasizes collaborative care for preventing deaths.

Bayer's OASIS 3 trial affirmsed the safety and efficacy of elinzanetant in reducing moderate to severe vasomotor symptoms, bolstering confidence in its potential as a non-hormonal solution for menopause-related issues.

A study reveals that urobiome community types characterized by fewer Lactobacilli and greater bacterial diversity are associated with increased urinary incontinence episodes.

Delve into the connection between nighttime vasomotor symptoms and Alzheimer's disease risk in women, shedding light on potential modifiable factors impacting cognitive health.

A recent study sheds light on the significant association between alcohol use disorder and suicide mortality found regardless of sex, emphasizing the importance of addressing alcohol use disorder in suicide prevention strategies.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Marlena S. Fejzo, PhD, sheds light on Harmonia Healthcare's innovative approach to tackling hyperemesis gravidarum, offering personalized care and telehealth options to address unmet patient needs and reduce emergency room visits.

A recent study reveals the efficacy of a cognitive behavior therapy program, showcasing significant improvements in health-related quality of life among women grappling with moderate to severe overactive bladder.

A recent study from the National Institutes of Health reveals an intervention led by non-specialist providers during pregnancy significantly lowers postpartum depression and anxiety risks, especially crucial for women in resource-poor settings where mental health care access is limited.

Discover how the early transition to menopause can affect women's work ability and workforce participation, shedding light on crucial considerations for both healthcare providers and employers.

Grace Ferguson, MD, MPH, generalist ob-gyn at Allegheny Health Network, sheds light on gender-based discrepancies in medicine, emphasizing both progress and persistent challenges.

A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.

A recent study delves into how serum estradiol decline preceding human chorionic gonadotropin administration affects in vitro fertilization outcomes, particularly among patients without oral contraceptive pretreatment, shedding light on the importance of monitoring during controlled ovarian hyperstimulation.

Discover how myo-inositol supplementation improves hormonal imbalances and metabolic irregularities in women with polycystic ovary syndrome, offering hope for effective treatment.

Investigating dysmenorrhea outcomes with low-dose pill prescriptions reveals no significant difference between combination telemedicine and in-person consultations vs in-person only, prompting further exploration into telemedicine's role in gynecological care.

Explore how adverse childhood experiences affect various reproductive events in women, shedding light on the correlation between early life challenges and accelerated reproductive milestones.

A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Investigating the potential association between second-stage cesarean delivery and heightened preterm birth risk revealed significant findings amidst concerns of bias, urging further exploration.

Investigating the relationship between 25-hydroxyvitamin D (25OHD) levels and miscarriage risk, a recent study utilizing mendelian randomization analysis found minimal causal association, suggesting no significant impact of vitamin D deficiency on miscarriage risk.

Recent research suggested that despite concerns about valproate use during pregnancy, prenatal exposure to antiseizure medications does not appear to raise the risk of epilepsy in offspring.

A recent study highlighted the disparity between dietary recommendations and actual intake of fish and omega-3 supplements among pregnant women, underscoring the need for targeted public health interventions to address this shortfall.

Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.

Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.

A recent study assessed the effectiveness of GeneXpert point-of-care testing in detecting chlamydia, gonorrhoea, and trichomonas, revealing promising results but highlighting concerns over sensitivity rates, particularly for trichomonas.

Recent findings affirm the safety of monthly dapivirine vaginal rings and daily oral PrEP with tenofovir disoproxil fumarate and emtricitabine in preventing HIV transmission among pregnant cisgender women.